A smile full of hope.

Infantile hemangioma is a benign growth of blood vessels that commonly appears during the first weeks or months of a baby’s life. These soft, raised, reddish or purplish marks are the most common tumors of infancy. They often grow rapidly during the first few months before entering a slower phase and, in many cases, gradually shrink and fade over the following years.

While most infantile hemangiomas are harmless and resolve on their own, location and size matter. Those on the face—especially the nose, lips, or around the eyes—can raise concerns about appearance, breathing, vision, or feeding, and may benefit from early evaluation. High-risk features include rapid growth, ulceration, or proximity to vital structures. Treatment options, when needed, include oral propranolol (the current first-line medication), topical timolol for smaller superficial lesions, laser therapy, or, less commonly, surgery for residual changes after involution.

The cheerful baby in these photos, with a prominent nasal hemangioma, reminds us that every child has a unique health journey. Behind the visible mark is a little person full of joy and personality. Many families navigate the uncertainty of growth phases, medical appointments, and decisions about whether and when to treat, all while focusing on their child’s comfort and happiness.

Every child undergoing evaluation or treatment deserves to be surrounded by strength, comfort, and loving support. Raising awareness helps reduce unnecessary worry and stigma, encourages timely specialist care when indicated, and fosters kindness toward children whose appearance differs from the expected.

Let’s continue to share accurate information, offer empathy, and treat every child with the respect and acceptance they deserve. A smile like this one shows that hope and resilience shine through—even when a small mark tells part of the story.

Sources

• American Academy of Pediatrics clinical guidelines and pediatric dermatology reviews on infantile hemangioma: natural history (proliferation and involution), high-risk locations (including nasal tip), indications for treatment, and first-line therapies such as propranolol
• Awareness-focused materials emphasizing supportive care, reduction of stigma, and the importance of individualized evaluation for infants with facial hemangiomas